High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors

被引:34
作者
Olsen, MH [1 ]
Christensen, MK
Hansen, TW
Gustafsson, F
Rasmussen, S
Wachtell, K
Borch-Johnsen, K
Ibsen, H
Jorgensen, T
Hildebrandt, P
机构
[1] Rigshosp, Dept Cardiol, DK-2100 Copenhagen 0, Denmark
[2] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark
[3] Glostrup Univ Hosp, Dept Clin Physiol & Nucl Med, Glostrup, Denmark
[4] Frederiksberg Univ Hosp, Dept Cardiol, Frederiksberg, Denmark
[5] Steno Diabet Ctr, Gentofte, Denmark
[6] Glostrup Univ Hosp, Dept Internal Med, Glostrup, Denmark
关键词
24-hour ambulatory blood pressure; albuminuria; atherosclerotic plaques; cardiovascular risk factors; carotid arteries; high sensitivity C-reactive protein; inflammation; left ventricular hypertrophy; metabolic syndrome; pulse wave velocity;
D O I
10.1097/01.hjh.0000217847.03208.ba
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background The independent prognostic value of high-sensitivity C-reactive protein (hsCRP) has been questioned, and consequently we decided to investigate whether hsCRP was associated with subclinical cardiovascular (CV) damage independently of traditional CV risk factors. Methods In a population-based sample of 2028 apparently healthy individuals without prior stroke or myocardial infarction not receiving any CV, anti-diabetic or lipid-lowering treatment, aged 41, 51, 61 or 71 years, we measured in 1993 serum hsCRP, traditional CV risk factors (lifestyle, metabolic and hemodynamic) and assessed subclinical CV damage [atherosclerotic plaques in the carotid arteries, pulse wave velocity (PWV), urine albumin/creatinine ratio (UACR), left ventricular (LV) mass and ejection fraction]. Results Adjusting for age and gender in multiple regression analyses, higher log(hsCRP) was associated with higher logPWV (beta = 0.15) and log(left ventricular mass index) (LVMI) (0 = 0.09, both beta < 0.001), LV relative wall thickness (beta = 0.07, P < 0.01), logUACR (beta = 0.04, P = 0.06) and more atherosclerotic plaques (P = 0.06, P < 0.05). However, higher log(hsCRP) was only weakly associated with higher logPWV(beta = 0.06, P < 0.05) and more atherosclerotic plaques (beta = 0.04, P = 0.06) when adjusting for other significant CV risk factors, such as daily smoking (P = 0.18), female gender (beta = -0.17), older age (beta = 0.11), lower log(high density lipoprotein cholesterol) (beta = -0.11, all P < 0.001); wider waist (beta = 0.17), higher body mass index (beta = 0.14), higher heart rate (beta = 0.06, all P < 0.01); and higher log(plasma glucose) (beta = 0.05, P < 0.05) (adj. R-2 = 0.19, P < 0.001). Conclusion After adjustment for traditional CV risk factors hsCRP was only associated with PWV and atherosclerotic plaques, indicating a possible effect of low-grade inflammation on macrovascular damage. The close relationship between traditional CV risk factors and hsCRP suggested that hsCRP was an integrated CV risk marker early in the development of atherosclerosis.
引用
收藏
页码:655 / 661
页数:7
相关论文
共 32 条
[1]   Blood pressure, C-reactive protein, and risk of future cardiovascular events [J].
Blake, GJ ;
Rifai, N ;
Buring, JE ;
Ridker, PM .
CIRCULATION, 2003, 108 (24) :2993-2999
[2]   Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses [J].
Danesh, J ;
Whincup, P ;
Walker, M ;
Lennon, L ;
Thomson, A ;
Appleby, P ;
Gallimore, JR ;
Pepys, MB .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :199-204
[3]   C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].
Danesh, J ;
Wheeler, JG ;
Hirschfield, GM ;
Eda, S ;
Eiriksdottir, G ;
Rumley, A ;
Lowe, GDO ;
Pepys, MB ;
Gudnason, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397
[4]   Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes [J].
Drivsholm, T ;
Ibsen, H ;
Schroll, M ;
Davidsen, M ;
Borch-Johnsen, K .
DIABETIC MEDICINE, 2001, 18 (02) :126-132
[5]   Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects:: The Insulin Resistance Atherosclerosis Study [J].
Festa, A ;
D'Agostino, R ;
Howard, G ;
Mykkänen, L ;
Tracy, RP ;
Haffner, SM .
KIDNEY INTERNATIONAL, 2000, 58 (04) :1703-1710
[6]   Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats [J].
Fitch, RM ;
Vergona, R ;
Sullivan, ME ;
Wang, YX .
CARDIOVASCULAR RESEARCH, 2001, 51 (02) :351-358
[7]   Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subject [J].
Guerrero-Romero, F ;
Rodríguez-Morán, M .
DIABETES & METABOLISM, 2003, 29 (01) :65-71
[8]   Relation between insulin and aortic stiffness: a population-based study [J].
Hansen, TW ;
Jeppesen, J ;
Rasmussen, S ;
Ibsen, H ;
Torp-Pedersen, C .
JOURNAL OF HUMAN HYPERTENSION, 2004, 18 (01) :1-7
[9]   Inflammatory markers and risk of developing type 2 diabetes in women [J].
Hu, FB ;
Meigs, JB ;
Li, TY ;
Rifai, N ;
Manson, JE .
DIABETES, 2004, 53 (03) :693-700
[10]   Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients -: Losartan intervention for endpoint reduction in hypertension study [J].
Ibsen, H ;
Olsen, MH ;
Wachtell, K ;
Borch-Johnsen, K ;
Lindholm, LH ;
Mogensen, CE ;
Dahlöf, B ;
Devereux, RB ;
de Faire, U ;
Fyhrquist, F ;
Julius, S ;
Kjeldsen, SE ;
Lederballe-Pedersen, O ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wan, Y .
HYPERTENSION, 2005, 45 (02) :198-202